Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zakaria Bouchouireb"'
Autor:
Zakaria Bouchouireb, Damien Olivier-Jimenez, Titouan Jaunet-Lahary, Steeve H. Thany, Jean-Yves Le Questel
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 281, Iss , Pp 116582- (2024)
Molecular docking, pivotal in predicting small-molecule ligand binding modes, struggles with accurately identifying binding conformations and affinities. This is particularly true for neonicotinoids, insecticides whose impacts on ecosystems require p
Externí odkaz:
https://doaj.org/article/3766600ed36e40198113435dde7ffd68
Autor:
Zakaria Bouchouireb, Rossana Sussarellu, Sabine Stachowski-Haberkorn, Jérôme Graton, Jean-Yves Le Questel
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba15cd36f5deab8004ef1c310a417da
https://doi.org/10.2139/ssrn.4064799
https://doi.org/10.2139/ssrn.4064799
Autor:
Damien Olivier-Jimenez, Zakaria Bouchouireb, Simon Ollivier, Julia Mocquard, Pierre-Marie Allard, Guillaume Bernadat, Marylène Chollet-Krugler, David Rondeau, Joël Boustie, Justin J.J. van der Hooft, Jean-Luc Wolfender
In the context of untargeted metabolomics, molecular networking is a popular and efficient tool which organizes and simplifies mass spectrometry fragmentation data (LC-MS/MS), by clustering ions based on a cosine similarity score. However, the nature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7679aefde9fb8d37adf3974a9c0ee2f
https://doi.org/10.1101/2021.12.21.473622
https://doi.org/10.1101/2021.12.21.473622
Autor:
Jean-Yves Masson, Adèle D. Laurent, Milena Popova, Cathy Charlier, Zakaria Bouchouireb, Pierre Weigel, Igor Nabiev, Denis Velic, Fabrice Fleury, Sebastien Henry, Titouan Jaunet-Lahary
Publikováno v:
Biochimie
Biochimie, Elsevier, 2019, 167, pp.187-197. ⟨10.1016/j.biochi.2019.09.016⟩
Biochimie, Elsevier, 2019, 167, pp.187-197. ⟨10.1016/j.biochi.2019.09.016⟩
Rad51 is a key protein in DNA repair by homologous recombination and an important target for development of drugs in cancer therapy. 4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) has been used in clinic during the past 30 years as an inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbe975435c8704aadbb6dbc93117f1bc
https://hal.archives-ouvertes.fr/hal-02359114/document
https://hal.archives-ouvertes.fr/hal-02359114/document